# EDGAR Filing Document

**Accession Number:** 0001944285
**File Stem:** 0000894189-25-011578
**Filing Date:** 2025-10
**Character Count:** 20280
**Document Hash:** 9542e993b682db53a815aa6fddc88fe8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000894189-25-011578.hdr.sgml**: 20251021

**ACCESSION NUMBER**: 0000894189-25-011578

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250831

**FILED AS OF DATE**: 20251021

**DATE AS OF CHANGE**: 20251021

**PERIOD START**: 20260228

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Tema ETF Trust
- **CENTRAL INDEX KEY:** 0001944285

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23823
- **FILM NUMBER:** 251406653

**BUSINESS ADDRESS:**
- **STREET 1:** 1919 M STREET, N.W., SUITE 700
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20036
- **BUSINESS PHONE:** 3024994928 EXT. 801

**MAIL ADDRESS:**
- **STREET 1:** 1919 M STREET, N.W., SUITE 700
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20036

## Series and Classes Contracts Data

### Tema Oncology ETF (Series ID: S000078299)

| Class ID   | Class Name        | Ticker Symbol   |
|:---|:---|:---|
| C000239059 | Tema Oncology ETF |  |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Tema ETF Trust

- **b. Investment Company Act file number:** 811-23823

- **c. CIK number of Registrant:** 0001944285

- **d. LEI of Registrant:** 549300JKGDXNE2CLUY37

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 200 Vesey Street

  - **City:** New York

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10281

  - **Telephone number:** 3024994928 EXT 801

**Item A.2. Information about the Series.**

- **a. Name of Series:** Tema Oncology ETF

- **b. EDGAR series identifier (if any):** S000078299

- **c. LEI of Series:** 549300N3IU4YD19QLF24

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-02-28

- **b. Date as of which information is reported:** 2025-08-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $70974462.45

**Total Liabilities:** $555814.11

**Net Assets:** $70418648.34

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000239059 | 3.79%                | 4.78%                | 2.72%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $861635.84               | $1676656.80                                |
| Month 2  | $988600.77               | $2322386.24                                |
| Month 3  | $-1051029.28             | $2902316.45                                |

**Designated Index Information**

- **Index Name:** N/A

- **Index Identifier:** N/A

### Schedule of Portfolio Investments

| Name                           | Title                                    | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Bristol-Myers Squibb Co        | Bristol-Myers Squibb Co                  | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |     45470 | NS      | $2145274.60   | 3.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Day One Biopharmaceuticals Inc | Day One Biopharmaceuticals Inc           | CUSIP: 23954D109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     43399 | NS      | $325926.49    | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Illumina Inc                   | Illumina Inc                             | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |      2990 | NS      | $298880.40    | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Iovance Biotherapeutics Inc    | Iovance Biotherapeutics Inc              | CUSIP: 462260100<br>LEI: 2549002L8WT2ACU5Q878 | Long             | EC               | CORP              | US        |    165150 | NS      | $368284.50    | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Chugai Pharmaceutical Co Ltd   | Chugai Pharmaceutical Co Ltd             | CUSIP: N/A<br>LEI: 529900T9LAII161DCN95       | Long             | EC               | CORP              | JP        |     14888 | NS      | $659426.30    | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Replimune Group Inc            | Replimune Group Inc                      | CUSIP: 76029N106<br>LEI: 549300AY704NEIRC4K64 | Long             | EC               | CORP              | US        |     40810 | NS      | $220374.00    | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Roche Holding AG               | Roche Holding AG                         | CUSIP: 771195104<br>LEI: 549300U41AUUVOAAOB37 | Long             | EC               | CORP              | CH        |     85054 | NS      | $3467651.58   | 4.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Summit Therapeutics Inc        | Summit Therapeutics Inc                  | CUSIP: 86627T108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     83376 | NS      | $1976011.20   | 2.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Daiichi Sankyo Co Ltd          | Daiichi Sankyo Co Ltd                    | CUSIP: N/A<br>LEI: 353800XGIU2IHQGC9504       | Long             | EC               | CORP              | JP        |     42807 | NS      | $1027973.89   | 1.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcus Biosciences Inc          | Arcus Biosciences Inc                    | CUSIP: 03969F109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     54537 | NS      | $577546.83    | 0.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Arvinas Inc                    | Arvinas Inc                              | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     36880 | NS      | $285082.40    | 0.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Guardant Health Inc            | Guardant Health Inc                      | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |      9781 | NS      | $659435.02    | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunocore Holdings PLC        | Immunocore Holdings PLC                  | CUSIP: 45258D105<br>LEI: 213800IUE3DFS84BVN18 | Long             | EC               | CORP              | GB        |     20306 | NS      | $654259.32    | 0.93%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc                     | AbbVie Inc                               | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |      9697 | NS      | $2040248.80   | 2.90%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                      | Amgen Inc                                | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |      5514 | NS      | $1586432.94   | 2.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Ascentage Pharma Group Interna | Ascentage Pharma Group International     | CUSIP: 04390B105<br>LEI: 300300WBVGZIXEF27W64 | Long             | EC               | CORP              | CN        |     14170 | NS      | $600524.60    | 0.85%             |  |  |  | No            |                  1 | On Loan: No      |
| BeOne Medicines Ltd            | BeOne Medicines Ltd                      | CUSIP: 07725L102<br>LEI: 549300JFUK6FRD5MH739 | Long             | EC               | CORP              | US        |      7057 | NS      | $2159794.85   | 3.07%             |  |  |  | No            |                  1 | On Loan: No      |
| First American Treasury Obliga | First American Treasury Obligations Fund | CUSIP: 31846V328<br>LEI: 549300UU586IAH2B8H03 | Long             | STIV             | RF                | US        |    124413 | NS      | $124412.61    | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| AnaptysBio Inc                 | AnaptysBio Inc                           | CUSIP: 032724106<br>LEI: 529900HH4WQT03IG1A12 | Long             | EC               | CORP              | US        |     10429 | NS      | $212021.57    | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                | AstraZeneca PLC                          | CUSIP: N/A<br>LEI: PY6ZZQWO2IZFZC3IOL08       | Long             | EC               | CORP              | GB        |     19285 | NS      | $3073151.00   | 4.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Celcuity Inc                   | Celcuity Inc                             | CUSIP: 15102K100<br>LEI: 25490070W7UU7W2SEY87 | Long             | EC               | CORP              | US        |     20929 | NS      | $1072192.67   | 1.52%             |  |  |  | No            |                  1 | On Loan: No      |
| CG oncology Inc                | CG oncology Inc                          | CUSIP: 156944100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     28713 | NS      | $770082.66    | 1.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Cogent Biosciences Inc         | Cogent Biosciences Inc                   | CUSIP: 19240Q201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     85415 | NS      | $1031813.20   | 1.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Cullinan Therapeutics Inc      | Cullinan Therapeutics Inc                | CUSIP: 230031106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     39017 | NS      | $294188.18    | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Exelixis Inc                   | Exelixis Inc                             | CUSIP: 30161Q104<br>LEI: 254900PJQB59O2O95R37 | Long             | EC               | CORP              | US        |     56291 | NS      | $2106409.22   | 2.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Genmab A/S                     | Genmab A/S                               | CUSIP: 372303206<br>LEI: 529900MTJPDPE4MHJ122 | Long             | EC               | CORP              | DK        |    118992 | NS      | $2959331.04   | 4.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc            | Gilead Sciences Inc                      | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |     12027 | NS      | $1358690.19   | 1.93%             |  |  |  | No            |                  1 | On Loan: No      |
| HUTCHMED China Ltd             | HUTCHMED China Ltd                       | CUSIP: 44842L103<br>LEI: 2138006X34YDQ6OBYE79 | Long             | EC               | CORP              | HK        |     38915 | NS      | $584114.15    | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunome Inc                   | Immunome Inc                             | CUSIP: 45257U108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    105481 | NS      | $1003124.31   | 1.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                 | Eli Lilly & Co                           | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |      3851 | NS      | $2821165.58   | 4.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co Inc                 | Merck & Co Inc                           | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |     18511 | NS      | $1557145.32   | 2.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvalent Inc                   | Nuvalent Inc                             | CUSIP: 670703107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     29037 | NS      | $2223653.46   | 3.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Nurix Therapeutics Inc         | Nurix Therapeutics Inc                   | CUSIP: 67080M103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     74137 | NS      | $692439.58    | 0.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvation Bio Inc               | Nuvation Bio Inc                         | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    127623 | NS      | $379040.31    | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Novartis AG                    | Novartis AG                              | CUSIP: N/A<br>LEI: 5493007HIVTX6SY6XD66       | Long             | EC               | CORP              | CH        |     25499 | NS      | $3223744.10   | 4.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals Inc  | Regeneron Pharmaceuticals Inc            | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |      1724 | NS      | $1001126.80   | 1.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Revolution Medicines Inc       | Revolution Medicines Inc                 | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |    101691 | NS      | $3861207.27   | 5.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Zai Lab Ltd                    | Zai Lab Ltd                              | CUSIP: 98887Q104<br>LEI: 549300P2UYQ9U5LY1T58 | Long             | EC               | CORP              | CN        |     58959 | NS      | $1951542.90   | 2.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Merus NV                       | Merus NV                                 | CUSIP: N/A<br>LEI: 549300W8GPUWU8QNU293       | Long             | EC               | CORP              | NL        |     46815 | NS      | $3082299.60   | 4.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Schrodinger Inc/United States  | Schrodinger Inc/United States            | CUSIP: 80810D103<br>LEI: 984500044BAE4791E559 | Long             | EC               | CORP              | US        |     15993 | NS      | $312023.43    | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcellx Inc                    | Arcellx Inc                              | CUSIP: 03940C100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     30969 | NS      | $2148938.91   | 3.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                      | Argenx SE                                | CUSIP: 04016X101<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |      1933 | NS      | $1376682.60   | 1.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Autolus Therapeutics PLC       | Autolus Therapeutics PLC                 | CUSIP: 05280R100<br>LEI: 549300C0KZP8EYROLL02 | Long             | EC               | CORP              | GB        |    110013 | NS      | $165019.50    | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Bridgebio Pharma Inc           | Bridgebio Pharma Inc                     | CUSIP: 10806X102<br>LEI: 54930028YG89VTY2J114 | Long             | EC               | CORP              | US        |     74622 | NS      | $3862434.72   | 5.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Enliven Therapeutics Inc       | Enliven Therapeutics Inc                 | CUSIP: 29337E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     29779 | NS      | $603620.33    | 0.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Ideaya Biosciences Inc         | Ideaya Biosciences Inc                   | CUSIP: 45166A102<br>LEI: 549300ULW08F62IJML11 | Long             | EC               | CORP              | US        |     63694 | NS      | $1563687.70   | 2.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Janux Therapeutics Inc         | Janux Therapeutics Inc                   | CUSIP: 47103J105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     38335 | NS      | $870971.20    | 1.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Legend Biotech Corp            | Legend Biotech Corp                      | CUSIP: 52490G102<br>LEI: 254900EIUFZTW136H859 | Long             | EC               | CORP              | US        |     51813 | NS      | $1799465.49   | 2.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Relay Therapeutics Inc         | Relay Therapeutics Inc                   | CUSIP: 75943R102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     88775 | NS      | $318702.25    | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Syndax Pharmaceuticals Inc     | Syndax Pharmaceuticals Inc               | CUSIP: 87164F105<br>LEI: 529900OF94TRHKZVBS87 | Long             | EC               | CORP              | US        |     78876 | NS      | $1288045.08   | 1.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Zymeworks Inc                  | Zymeworks Inc                            | CUSIP: 98985Y108<br>LEI: 894500AHOYAGYLYZJL67 | Long             | EC               | CORP              | US        |     60471 | NS      | $895575.51    | 1.27%             |  |  |  | No            |                  1 | On Loan: No      |
| UroGen Pharma Ltd              | UroGen Pharma Ltd                        | CUSIP: N/A<br>LEI: 549300C0YCX7CG2G5D50       | Long             | EC               | CORP              | US        |     37447 | NS      | $728344.15    | 1.03%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-10-20

**Name of Applicant:** Tema ETF Trust

**Signature:** /s/ Josh Hunter

**Name of Signer:** Josh Hunter

**Title:** Treasurer